CYBIN INC.
For the period ended Mar 31, 2025. Filed Jul 1, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2025 · Filed Jul 1, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · Foreign Operations
Foreign Operations
In addition to operations carried out in Canada and the UK, the Company intends to carry out international operations through an office in Ireland. As a result, the Company may be subject to political, economic and other uncertainties, including, but not limited to, additional implications that may have a material impact on the Company’s ability to operate in other jurisdictions including:
differences in the regulatory requirements for drug approvals;
differing requirements for securing, maintaining or obtaining freedom to operate;
the potential for reduced protection for intellectual property rights;
challenges with compliance to different regulations and court systems of multiple jurisdictions and
compliance with a wide variety of foreign laws, treaties and regulations;
differing reimbursement regimes and price controls in certain international markets;
differing labor relations that create challenges with staffing and managing international operations; and
impacts on manufacturing capabilities leading to production shortages.
The Company’s international operations may also be adversely affected by laws and policies of Canada affecting foreign trade, taxation and investment. In the event of a dispute arising in connection with its foreign operations, the Company may be subject to the exclusive jurisdiction of foreign courts or may not be successful in subjecting foreign persons to the jurisdiction of courts in Canada or enforcing Canadian judgments in foreign jurisdictions.
Similarly, to the extent that the Company’s assets are located outside of Canada, investors may have difficulty collecting from the Company any judgments obtained in the Canadian courts and predicated on the civil liability provisions of securities laws. Consequently, investors may be effectively prevented from pursuing remedies against the Company under Canadian securities laws or otherwise. The Company may also be hindered or prevented from enforcing its rights with respect to a governmental entity or instrumentality because of the doctrine of sovereign immunity.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.